Screener
Atea Pharmaceuticals, Inc. AVIR Q3 2025 earnings
Reported November 12, 2025 · After market close
EPS-$0.53Miss by $0.07
EPS estimate-$0.46
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$50.4M
EPS estimate-$0.51
Versus estimates
Diluted EPS
FAQ
- When did Atea Pharmaceuticals, Inc. report Q3 2025 earnings?
- Atea Pharmaceuticals, Inc. (AVIR) reported Q3 2025 earnings on November 12, 2025 after market close.
- What were Atea Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
- Atea Pharmaceuticals, Inc. reported eps of $-0.53 for Q3 2025.
- Did Atea Pharmaceuticals, Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.46 by $0.07.
- How did Atea Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 43.2% from $-0.37.
- Where can I find Atea Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-277627) and the 10-Q periodic report (0001193125-25-277815) directly on SEC EDGAR. The filing index links above go to sec.gov.
